The Director Asst. Professor Soykan Agar explained the updates of his studies to TRT, Ihlas and Anadolu agencies as the following:

''Within our in silico de novo drug design & repurposing group using a supercomputer infrastructure, we design new oncological and neuro-oncological drugs and test their drug indication capabilities using molecular docking, molecular dynamics and AI software. 

We have collaborations world-wide and apply in silico, in vitro and in vivo approach to drug candidates. I am glad to say that our university Rector Professor Muzaffer Elmas is a visionary leader who sees the future of academic life and discoveries and educates us in that sense where this affects the quality and quantity of our research papers and patents.''